Money: The Best ETFs For 2018
Investing in stocks can be lucrative, but for a lot of people, it can also be devastating — picking wrong can put a big dent in your nest egg. Enter exchange-traded funds — baskets of securities collectively traded like stocks — which have a partial answer to that. It’s a great time for ETF investing ideas, with no shortage of options out there.
At the end of 2017, there were roughly 5,000 exchange-traded funds worldwide — with about 2,000 right here in the U.S. But how do you find the best ETFs to buy for 2018 in this sea of choices, This sixth annual installment of the MoneySense ETF All-Stars should reassure long-time, passive, buy-and-hold investors as we largely have stayed the course, albeit with three additions and the creation of a new game-changing category. Our expert panel is intact from last year, although we have added Karen Tsang from Forstrong for some overdue gender diversity.
And all our 2017 picks have returned, which is as it should be. Even though the number of ETFs available on Canadian stock exchanges had surged to 583 by the end of February, the number of ETF All-Stars is at a manageable 20, up from 14 last year. Instagram announced some changes to user feeds today, but before you get too excited, no it's not a return to the chronological feed. Additionally, your feed will no longer automatically refresh and jump back to the top.
Instead, users will be able to tap a "New Posts" button that will take them to the top of their feed when they want to see new posts. That means an investment in ROBO could pay off big time in 2018 . With more than billion in assets under management, this ETF is hardly a fad.
7 of the Best Blue-Chip Stocks to Buy for 2018 . There are several good reasons to invest in airline stocks and 2018 could see the category reporting new highs. Here are the best ETFs in this sector for 2018 . 129.53 billion, bringing the total number of providers to 24, according to the Canadian ETF Association (CETFA). Each year, the MoneySense All-Stars panel’s challenge is to balance all this product innovation with our core principles of low costs, broad diversification and tax efficiency. Tiger Woods announced Monday that he will play in the 2018 National to be held between June 25 and July 1 at TPC Potomac.
And one of the things that really recommends this particular ETF is its expense ratio. Read more about QQQ here. The SPDR S&P Biotech (ETF) (NYSEARCA:XBI) has been in the running basically since the start. This equal-weighted fund covers more than 100 of the best biotechs available on the markets. The market stress that shook the markets in March brought down a number of stocks, and the members of the XBI ETF were not really an exception.
However, it has held up better than many areas of the markets, certainly outstripping the SPDR S&P 500 ETF Trust (NYSEARCA:SPY) over the first quarter. Can it keep the strength up and take the top spot in the Best ETFs contest, Like VSS, the iShares Emerging Markets Dividend ETF (NYSEARCA:DVYE) is focused on emerging markets — though in this case, instead of small-cap names, it puts the spotlight on dividend stocks.
That different focus has helped DVYE do a little better than VSS so far, and it could be looking forward to more growth — or at the very least, hold up better than U.S. As Sizemore wrote, “As I write this, the market is in sell-off mode, in part due to fears that U.S. If that gets worse, investors should look even more toward emerging markets to help their portfolios. Read more about DVYE from Charles Sizemore here. Do you know what’s been helping ALPS Medical Breakthrough ETF (NYSEARCA:SBIO) duke it out for the second spot for more of 2018,
It’s not just having some great biotech names — though that helps. No, one of the great things about SBIO is how many of these companies could look attractive to larger companies with M&A in mind. As Shriber says, “No, not all of the fund’s constituents will be acquired. Still, this biotech ETF is home to multiple legitimate takeover targets.
